🕒 Wednesday 29 April 2026 Wed, 29 Apr 2026

Lodestar Minerals has confirmed visible copper and IOCG-style mineralisation in its second drill hole at the Three Saints Project, extending the mineralised system over a 700-metre strike length. Drilling is ongoing with assay results expected by early July.

Syntara Limited has raised A$10 million through a two-tranche placement and share purchase plan, backing its Phase 2b myelofibrosis trial and multiple clinical readouts following positive FDA feedback.

Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.

Green Technology Metals (ASX: GT1) sharpens focus on its Seymour Lithium Project amid a lithium price rebound, key permitting progress, and extended C$100 million financing interest from Export Development Canada.

PTR Minerals delivered standout assay results from its Rosewood Titanium Project, confirming extensive high-grade mineralisation and strong metallurgical performance, keeping its maiden JORC resource estimate on track for Q2 2026.

Neurotech International has opened its first Phase 3 clinical site for NTI164 targeting Autism Spectrum Disorder, reported positive 90-day toxicology results, and launched a new Rett syndrome research collaboration.

PhosCo Ltd has reported rock chip assays up to 21.3% copper and 100 g/t silver from the King’s Eye prospect within its Simitu Project in northern Tunisia, alongside geophysical evidence of sulphide mineralisation at depth warranting immediate follow-up.

Anax Metals’ updated DFS for Whim Creek reveals a 113% surge in free cash flow to A$723 million, underpinned by a decade-long mine life and rapid payback. The company’s $10 million capital raise strengthens its balance sheet following full repayment of a $3.5 million loan.

eMetals Limited has solidified its foothold in high-grade tungsten with a binding acquisition in Utah, while its Ugandan gold projects reveal promising soil anomalies amid ongoing exploration.

Carma Limited surged past prior year sales with 1,344 units sold, boosted by rapid network expansion and improved reconditioning efficiency, while maintaining a solid cash position.

Terra Metals has linked two drill holes to reveal a 172.4-metre continuous zone of platinum group metals, copper, and nickel mineralisation at its Southwest Prospect, Dante Project, with high-grade pockets up to 31.11 g/t PGE3. The system remains open for expansion along strike and at depth.

Nickel Industries delivered its strongest quarterly earnings since late 2023, propelled by a 222% jump in ore sales and significant margin improvements across its nickel processing operations amid favourable regulatory changes and rising nickel prices.

MB Gold Limited (ASX:MBG) has kicked off a significant 6,000-metre drilling program at its Marble Bar Gold Project following a successful $9 million IPO. The company also secured a Heritage Protection Agreement with the Nyamal Aboriginal Corporation, underlining its commitment to responsible exploration in the Pilbara.

CZR Resources has unveiled strong assay results from its Croydon Gold Project, confirming a significant gold system open in all directions. The company advances exploration at Edamurta and Yarrie, supported by a robust cash position.

Hammer Metals has launched a new drilling phase at its Kalman Critical Metals Project while identifying fresh large-scale targets across its Mount Isa portfolio. Joint venture drilling at Bullrush and Isa Valley delivers promising copper and zinc results, complemented by a mining lease application at Orelia North in the Yandal gold belt.

Minerals 260 has secured a $59.1 million fixed-price contract with ATCO to build a 400-person accommodation village at its Bullabulling Gold Project, marking a key step towards construction readiness.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.

Cleo Diagnostics (ASX:COV) has hit a major milestone by completing sample collection for its pivotal U.S. ovarian cancer trial, while progressing manufacturing and analytical validation steps toward FDA 510(k) submission.

Caprice Resources has confirmed significant extensions of high-grade gold mineralisation at its Island Gold Project, backed by a $12.74 million capital raise and a new multi-rig drilling campaign.

Dundas Minerals has secured $2.5 million to fund extensive drilling across its Western Australian gold portfolio, exercised its option to acquire the Rockland mining lease, and expanded the Romano project with a new exploration licence application near Gruyere.

Horizon Gold has reported strong high-grade gold intercepts from drilling at its Omega and Kingfisher prospects in Western Australia, extending mineralisation and advancing its feasibility study on a 2.3 million ounce resource base.

Neometals Ltd has launched a 1-for-6 entitlement offer at A$0.04 per share alongside a two-tranche placement, targeting a combined A$13 million to advance gold and critical minerals projects.

Metal Bank is pushing towards near-term gold production in Western Australia and expanding its critical minerals footprint in Queensland, backed by new processing partnerships and exploration milestones.

West Wits Mining has poured its first gold at Qala Shallows, marking its transition to production, while securing substantial funding and advancing plans to scale output.